Patients with THTR2 reduced-activity variants are at increased risk for Wernicke’s encephalopathy, a severe neurological condition caused by prolonged thiamine deficiency through malnutrition or malabsorption [50]. This evidence concerns the gene SLC19A3 and Wernicke encephalopathy.